Retinitis Pigmentosa (due to CNGA1 mutation)
Conditions
Interventions
None listed
Sponsors
VeonGen Therapeutics GmbH
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Countries
Germany
Outcome results
None listed